Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gilmore

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
The Journal of Pathology|May 1, 1987
Pathogenicity of HIV in lymphatic organs of patients with AIDSD D Pekovic, M Gornitsky, D Ajdukovic, et al.
HIV Medicine|June 4, 2014
Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapyJ-P Routy, J B Angel, M Patel, et al.
Clinical and Experimental Immunology|June 14, 2014
Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infectionM-A Jenabian, M Patel, I Kema, et al.
HIV Medicine|October 4, 2003
Interleukin-7 levels may predict virological response in advanced HIV-1-infected patients receiving lopinavir/ritonavir-based therapyM R Boulassel, G H R Smith, N Gilmore, et al.
HIV Medicine|July 14, 2005
Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapyM R Boulassel, G H R Smith, M D de B Edwardes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2015
Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell CountsWei Cao, Vikram Mehraj, Benoit Trottier, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
The Journal of Pathology|May 1, 1987
Pathogenicity of HIV in lymphatic organs of patients with AIDSD D Pekovic, M Gornitsky, D Ajdukovic, et al.
HIV Medicine|June 4, 2014
Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapyJ-P Routy, J B Angel, M Patel, et al.
Clinical and Experimental Immunology|June 14, 2014
Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infectionM-A Jenabian, M Patel, I Kema, et al.
HIV Medicine|October 4, 2003
Interleukin-7 levels may predict virological response in advanced HIV-1-infected patients receiving lopinavir/ritonavir-based therapyM R Boulassel, G H R Smith, N Gilmore, et al.
HIV Medicine|July 14, 2005
Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapyM R Boulassel, G H R Smith, M D de B Edwardes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2015
Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell CountsWei Cao, Vikram Mehraj, Benoit Trottier, et al.
Pageof 5